180 related articles for article (PubMed ID: 16230414)
1. Anti-prostate stem cell antigen monoclonal antibody 1G8 induces cell death in vitro and inhibits tumor growth in vivo via a Fc-independent mechanism.
Gu Z; Yamashiro J; Kono E; Reiter RE
Cancer Res; 2005 Oct; 65(20):9495-500. PubMed ID: 16230414
[TBL] [Abstract][Full Text] [Related]
2. Anti-PSCA mAbs inhibit tumor growth and metastasis formation and prolong the survival of mice bearing human prostate cancer xenografts.
Saffran DC; Raitano AB; Hubert RS; Witte ON; Reiter RE; Jakobovits A
Proc Natl Acad Sci U S A; 2001 Feb; 98(5):2658-63. PubMed ID: 11226295
[TBL] [Abstract][Full Text] [Related]
3. Prostate stem cell antigen is a putative target for immunotherapy in pancreatic cancer.
Wente MN; Jain A; Kono E; Berberat PO; Giese T; Reber HA; Friess H; Büchler MW; Reiter RE; Hines OJ
Pancreas; 2005 Aug; 31(2):119-25. PubMed ID: 16024997
[TBL] [Abstract][Full Text] [Related]
4. Targeting, imaging, and therapy using a humanized antiprostate stem cell antigen (PSCA) antibody.
Olafsen T; Gu Z; Sherman MA; Leyton JV; Witkosky ME; Shively JE; Raubitschek AA; Morrison SL; Wu AM; Reiter RE
J Immunother; 2007; 30(4):396-405. PubMed ID: 17457214
[TBL] [Abstract][Full Text] [Related]
5. RNA interference targeting PSCA suppresses primary tumor growth and metastasis formation of human prostate cancer xenografts in SCID mice.
Zhao Z; He J; Kang R; Zhao S; Liu L; Li F
Prostate; 2016 Feb; 76(2):184-98. PubMed ID: 26477693
[TBL] [Abstract][Full Text] [Related]
6. Fluorescent Image-Guided Surgery with an Anti-Prostate Stem Cell Antigen (PSCA) Diabody Enables Targeted Resection of Mouse Prostate Cancer Xenografts in Real Time.
Sonn GA; Behesnilian AS; Jiang ZK; Zettlitz KA; Lepin EJ; Bentolila LA; Knowles SM; Lawrence D; Wu AM; Reiter RE
Clin Cancer Res; 2016 Mar; 22(6):1403-12. PubMed ID: 26490315
[TBL] [Abstract][Full Text] [Related]
7. Prostate stem cell antigen as therapy target: tissue expression and in vivo efficacy of an immunoconjugate.
Ross S; Spencer SD; Holcomb I; Tan C; Hongo J; Devaux B; Rangell L; Keller GA; Schow P; Steeves RM; Lutz RJ; Frantz G; Hillan K; Peale F; Tobin P; Eberhard D; Rubin MA; Lasky LA; Koeppen H
Cancer Res; 2002 May; 62(9):2546-53. PubMed ID: 11980648
[TBL] [Abstract][Full Text] [Related]
8. Dual antigen target-based immunotherapy for prostate cancer eliminates the growth of established tumors in mice.
Karan D; Dubey S; Van Veldhuizen P; Holzbeierlein JM; Tawfik O; Thrasher JB
Immunotherapy; 2011 Jun; 3(6):735-46. PubMed ID: 21668311
[TBL] [Abstract][Full Text] [Related]
9. Humanized radioiodinated minibody for imaging of prostate stem cell antigen-expressing tumors.
Leyton JV; Olafsen T; Lepin EJ; Hahm S; Bauer KB; Reiter RE; Wu AM
Clin Cancer Res; 2008 Nov; 14(22):7488-96. PubMed ID: 19010866
[TBL] [Abstract][Full Text] [Related]
10. An affinity matured minibody for PET imaging of prostate stem cell antigen (PSCA)-expressing tumors.
Lepin EJ; Leyton JV; Zhou Y; Olafsen T; Salazar FB; McCabe KE; Hahm S; Marks JD; Reiter RE; Wu AM
Eur J Nucl Med Mol Imaging; 2010 Aug; 37(8):1529-38. PubMed ID: 20354850
[TBL] [Abstract][Full Text] [Related]
11. Human prostate stem cell antigen and HSP70 fusion protein vaccine inhibits prostate stem cell antigen-expressing tumor growth in mice.
Dong L; Zhang X; Ren J; Wu S; Yu T; Hou L; Fu L; Yi S; Yu C
Cancer Biother Radiopharm; 2013 Jun; 28(5):391-7. PubMed ID: 23701419
[TBL] [Abstract][Full Text] [Related]
12. Prostate stem cell antigen (PSCA) expression increases with high gleason score, advanced stage and bone metastasis in prostate cancer.
Gu Z; Thomas G; Yamashiro J; Shintaku IP; Dorey F; Raitano A; Witte ON; Said JW; Loda M; Reiter RE
Oncogene; 2000 Mar; 19(10):1288-96. PubMed ID: 10713670
[TBL] [Abstract][Full Text] [Related]
13. Applications of immunoPET: using 124I-anti-PSCA A11 minibody for imaging disease progression and response to therapy in mouse xenograft models of prostate cancer.
Knowles SM; Tavaré R; Zettlitz KA; Rochefort MM; Salazar FB; Jiang ZK; Reiter RE; Wu AM
Clin Cancer Res; 2014 Dec; 20(24):6367-78. PubMed ID: 25326233
[TBL] [Abstract][Full Text] [Related]
14. Engineered humanized diabodies for microPET imaging of prostate stem cell antigen-expressing tumors.
Leyton JV; Olafsen T; Sherman MA; Bauer KB; Aghajanian P; Reiter RE; Wu AM
Protein Eng Des Sel; 2009 Mar; 22(3):209-16. PubMed ID: 18957406
[TBL] [Abstract][Full Text] [Related]
15. Radiolabeled anti-claudin 4 and anti-prostate stem cell antigen: initial imaging in experimental models of pancreatic cancer.
Foss CA; Fox JJ; Feldmann G; Maitra A; Iacobuzio-Donohue C; Kern SE; Hruban R; Pomper MG
Mol Imaging; 2007; 6(2):131-9. PubMed ID: 17445507
[TBL] [Abstract][Full Text] [Related]
16. Prostate stem cell antigen vaccination induces a long-term protective immune response against prostate cancer in the absence of autoimmunity.
Garcia-Hernandez Mde L; Gray A; Hubby B; Klinger OJ; Kast WM
Cancer Res; 2008 Feb; 68(3):861-9. PubMed ID: 18245488
[TBL] [Abstract][Full Text] [Related]
17. MRl of prostate cancer antigen expression for diagnosis and immunotherapy.
Ren J; Wang F; Wei G; Yang Y; Liu Y; Wei M; Huan Y; Larson AC; Zhang Z
PLoS One; 2012; 7(6):e38350. PubMed ID: 22761679
[TBL] [Abstract][Full Text] [Related]
18. The Anti-Proliferative Effect of a Newly-Produced Anti-PSCA-Peptide Antibody by Multiple Bioinformatics Tools, on Prostate Cancer Cells.
Chizari M; Fani-Kheshti S; Taeb J; Farajollahi MM; Mohsenzadegan M
Recent Pat Anticancer Drug Discov; 2021; 16(1):73-83. PubMed ID: 33176663
[TBL] [Abstract][Full Text] [Related]
19. Alternative pathways to prostate carcinoma activate prostate stem cell antigen expression.
Dubey P; Wu H; Reiter RE; Witte ON
Cancer Res; 2001 Apr; 61(8):3256-61. PubMed ID: 11309275
[TBL] [Abstract][Full Text] [Related]
20. Redirection of CD4+ and CD8+ T lymphocytes via a novel antibody-based modular targeting system triggers efficient killing of PSCA+ prostate tumor cells.
Arndt C; Feldmann A; Töpfer K; Koristka S; Cartellieri M; Temme A; Ehninger A; Ehninger G; Bachmann M
Prostate; 2014 Sep; 74(13):1347-58. PubMed ID: 25053504
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
